A very interesting article by seeking alpha on the competitive position of Centrus for HALEU production. The report covers URENCO, Silex and ASP isotopes (not too much on ASP) but also points out the the U234 in centrifuge production could be a problem for HALEU (compared to LIS) which is an aspect I was not particularly aware of. The report appears to not recognize the current advanced status of LIS and the other advantages of the Silex technology (i.e flexibility of product assay, cheap DoE tails as feedstock etc)
The article is more than 50,000 characters which appear to be a limit on what can be posted but the link is below:
https://seekingalpha.com/article/4606693-centrus-energy-continue-owning-for-near-term-upside-beware-longer-term-risks
The separate report on U234 issues in enriched uranium is:
https://www-pub.iaea.org/MTCD/publications/PDF/te_1529_web.pdf
- Forums
- ASX - By Stock
- Centrus views on HALEU RFP
SLX
silex systems limited
Add to My Watchlist
2.25%
!
$4.34

A very interesting article by seeking alpha on the competitive...
Featured News
Add to My Watchlist
What is My Watchlist?
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.
|
|||||
Last
$4.34 |
Change
-0.100(2.25%) |
Mkt cap ! $1.033B |
Open | High | Low | Value | Volume |
$4.54 | $4.61 | $4.32 | $3.963M | 895.8K |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
2 | 16533 | $4.31 |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
$4.39 | 3059 | 1 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
1 | 1162 | 4.310 |
1 | 338 | 4.260 |
1 | 1185 | 4.210 |
2 | 22090 | 4.200 |
1 | 1130 | 4.180 |
Price($) | Vol. | No. |
---|---|---|
4.410 | 28344 | 1 |
4.520 | 571 | 1 |
4.560 | 800 | 1 |
4.570 | 11982 | 1 |
4.580 | 25000 | 1 |
Last trade - 16.10pm 27/06/2025 (20 minute delay) ? |
Featured News
SLX (ASX) Chart |
The Watchlist
PAR
PARADIGM BIOPHARMACEUTICALS LIMITED..
Paul Rennie, MD & Founder
Paul Rennie
MD & Founder
SPONSORED BY The Market Online